In a recent press release, clinical stage biotech and biopharmaceutical company Biom Therapeutics (“Biom”) shared that its drug candidate BIO017 was granted Orphan Drug designation.
Machine Learning Could Improve FXS Diagnostic Process- April 13, 2021
PODCAST: WAIT, HOW DO YOU SPELL THAT?
LATEST PATIENT WORTHY ARTICLES
Cancer Network recently reported that Jazz Pharmaceuticals’ Vyxeos was approved by the FDA to treat therapy-related pediatric patients one year or older who were
As Parkinson’s diseases slowly erodes a person’s control of their movement, many normal parts of life become much more difficult. In a new study
A Reader Responds: A Common Parasite With An Uncommon Name: Toxoplasma Gondii is Associated with Brain Cancer
A reader named Fiorella, recently reached out in response to an article we wrote entitled: A Common Parasite With An Uncommon Name: Toxoplasma Gondii is
Researchers from the University of Barcelona have recently found a new biomarker which may be able to diagnose Parkinson’s disease sooner. This biomarker is a
STUDY OF THE WEEK
April 14 @ 6:00 pm - 7:00 pm
The MDS Foundation’s Clinical Implications of Genetic Mutations in Myelodysplastic Syndromes WebinarApril 17 @ 12:00 pm - 1:00 pm
April 19 @ 6:00 pm - 7:30 pm
April 20 @ 5:00 pm - 6:00 pm